(Q33154279)

22 July 2017

title

Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy (English)

1 reference

22 July 2017

0 references

phase I clinical trial

0 references

1

John Nemunaitis

1 reference

22 July 2017

Svetislava J Vukelja

2

1 reference

22 July 2017

Donald Richards

3

1 reference

22 July 2017

Casey Cunningham

4

1 reference

22 July 2017

Neil Senzer

5

1 reference

22 July 2017

John Nugent

6

1 reference

22 July 2017

Houston Duncan

7

1 reference

22 July 2017

Barry Jones

8

1 reference

22 July 2017

Eric Haltom

9

1 reference

22 July 2017

Margaret J Uprichard

10

1 reference

22 July 2017

publication date

1 October 2006

1 reference

22 July 2017

1 reference

22 July 2017

volume

24

1 reference

22 July 2017

issue

6

1 reference

22 July 2017

page(s)

553-561

1 reference

Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600894732

10.1080/07357900600894732

21 January 2018

Identifiers

DOI

1 reference

22 July 2017

1 reference